The White House on Wednesday said pharmaceutical firms risked damaging their reputations with big price hikes, but it sidestepped commenting directly on Mylan NV's decision to raise the price of its severe allergy treatment drug EpiPen.
http://ift.tt/2bgXP8i
0 التعليقات:
إرسال تعليق